FDA OKs new drug for hard-to-treat colitis and Crohn's

May 21, 2014
FDA OKs new drug for hard-to-treat colitis and crohn's
Injections of Entyvio may help when standard therapy for the digestive disorders has failed.

(HealthDay)—A new drug to treat adults with ulcerative colitis and Crohn's disease has been approved by the U.S. Food and Drug Administration.

The agency said Tuesday that injections of Entyvio (vedolizumab) can be used to treat with moderate to severe ulcerative colitis and Crohn's disease who have had poor responses to one or more of the current standard therapies: corticosteroids, immunomodulators, or tumor necrosis factor blocker medications.

The FDA's approval of the new drug is based on two clinical trials of about 900 patients with , and three clinical trials of about 1,500 patients with Crohn's disease.

Ulcerative colitis causes inflammation and ulcers in the inner lining of the large intestine and can lead to abdominal discomfort, bleeding and diarrhea. It affects about 620,000 Americans. Crohn's can cause inflammation and irritation in any part of the digestive tract. It affects more than 500,000 Americans.

"Ulcerative colitis and Crohn's disease are debilitating diseases that impact the quality of life of those who have these conditions," Dr. Amy Egan, acting deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said in an agency news release.

"Although there is no cure for these conditions, [Tuesday's] approval provides an important new treatment option for patients who have had an inadequate response to conventional therapy to help control their symptoms," she added.

Entyvio is a type of drug called an "integrin receptor antagonist." These drugs improve the function of cell-to-cell interactions, the FDA said. Another type of integrin receptor antagonist—Tysabri (natalizumab)—has been linked with a rare and often fatal infection of the central nervous system called progressive multifocal leukoencephalopathy (PML).

No cases of PML occurred in patients taking part in the clinical trials of Entyvio. But the risk for patients taking the new drug remains unclear and doctors should monitor patients who are taking Entyvio for any signs of PML, the FDA said.

The FDA told Entyvio's maker, Takeda Pharmaceuticals America Inc., that it must conduct a post-approval study to further investigate the risk of PML among patients taking Entyvio.

In the , the most common side effects among patients taking Entyvio included headache, joint pain, nausea and fever. The most serious side effects included major infections, injection-related reactions and liver toxicity.

Explore further: Simponi approved for ulcerative colitis

More information: The U.S. National Library of Medicine has more about ulcerative colitis and Crohn's disease.

Related Stories

Simponi approved for ulcerative colitis

May 15, 2013
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

Humira's approval widened to include ulcerative colitis

October 1, 2012
(HealthDay)—Humira (adalimumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe ulcerative colitis in adults, the agency said Friday.

Two studies identify potential new drug for Crohn's disease and ulcerative colitis

August 21, 2013
Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. ...

FDA investigating PML in patient taking MS drug

August 31, 2013
(HealthDay)—The U.S. Food and Drug Administration is investigating the possible association between a rare brain infection and the multiple sclerosis (MS) drug Gilenya (fingolimod), according to a drug safety alert issued ...

FDA approves new type 2 diabetes drug

April 15, 2014
(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

Fecal transplant studied for kids with bowel disease

April 17, 2013
(HealthDay)—Fecal transplantation—an innovative enema treatment—may help reduce or eliminate symptoms of ulcerative colitis in most children and young adults, according to a small study.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.